조현병의 병태생리 기전에서 성체 신경줄기세포 이상이 미치는 영향

키워드

참고문헌 (90)

1. Marder SR, "Schizophrenia", N Engl J Med, 381, pp.1753~1761 (2019)
2. Andreasen NC, "The diagnosis of schizophrenia", Schizophr Bull, 13, pp.9~22 (1987)
3. Insel TR, "Rethinking schizophrenia", Nature, 468, pp.187~193 (2010)
4. Harrison PJ, "The neuropathology of schizophrenia. A critical review of the data and their interpretation", Brain, 122, pp.593~624 (1999)
5. Rapoport JL, "Neurodevelopmental model of schizophrenia : update 2012", Mol Psychiatry, 17, pp.1228~1238 (2012)
6. Citri A, "Synaptic plasticity: multiple forms, functions, and mechanisms", Neuropsychopharmacology, 33, pp.18~41 (2008)
7. Bailey CH, "Structural components of synaptic plasticity and memory consolidation", Cold Spring Harb Perspect Biol, 7, pp.a021758~ (2015)
8. Sellgren CM, "Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning", Nat Neurosci, 22, pp.374~385 (2019)
9. Turrigiano GG, "Homeostatic plasticity in the developing nervous system", Nat Rev Neurosci, 5, pp.97~107 (2004)
10. Kempermann G, "Depressed new neurons--adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression", Biol Psychiatry, 54, pp.499~503 (2003)
11. Schloesser RJ, "Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder", Neuropsychopharmacology, 33, pp.110~133 (2008)
12. Haracz JL, "Neural plasticity in schizophrenia", Schizophr Bull, 11, pp.191~229 (1985)
13. Zarate CA Jr, "A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression", Arch Gen Psychiatry, 63, pp.856~864 (2006)
14. Bachmann RF, "Mood stabilizers target cellular plasticity and resilience cascades : implications for the development of novel therapeutics", Mol Neurobiol, 32, pp.173~202 (2005)
15. Reif A, "Neural stem cell proliferation is decreased in schizophrenia, but not in depression", Mol Psychiatry, 11, pp.514~522 (2006)
16. Morales AV, "Adult neural stem cells : born to last", Front Cell Dev Biol, 7, pp.96~ (2019)
17. Martino G, "The therapeutic potential of neural stem cells", Nat Rev Neurosci, 7, pp.395~406 (2006)
18. Sanai N, "Neural stem cells and the origin of gliomas", N Engl J Med, 353, pp.811~822 (2005)
19. Bond AM, "Adult mammalian neural stem cells and neurogenesis : five decades later", Cell Stem Cell, 17, pp.385~395 (2015)
20. Bédard A, "The rostral migratory stream in adult squirrel monkeys : contribution of new neurons to the olfactory tubercle and involvement of the antiapoptotic protein Bcl2", Eur J Neurosci, 16, pp.1917~1924 (2002)
21. Curtis MA, "Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension", Science, 315, pp.1243~1249 (2007)
22. Sanai N, "Corridors of migrating neurons in the human brain and their decline during infancy", Nature, 478, pp.382~386 (2011)
23. Sanai N, "Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration", Nature, 427, pp.740~744 (2004)
24. Mertens J, "Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder", Nature, 527, pp.95~99 (2015)
25. Brennand KJ, "Modelling schizophrenia using human induced pluripotent stem cells", Nature, 473, pp.221~225 (2011)
26. Shi Y, "Induced pluripotent stem cell technology : a decade of progress", Nat Rev Drug Discov, 16, pp.115~130 (2017)
27. Vierbuchen T, "Direct conversion of fibroblasts to functional neurons by defined factors", Nature, 463, pp.1035~1041 (2010)
28. Pfisterer U, "Direct conversion of human fibroblasts to dopaminergic neurons", Proc Natl Acad Sci U S A, 108, pp.10343~10348 (2011)
29. Arrojo E Drigo R, "Age mosaicism across multiple scales in adult tissues", Cell Metab, 30, pp.343~351 (2019)
30. Toyama BH, "Identification of long-lived proteins reveals exceptional stability of essential cellular structures", Cell, 154, pp.971~982 (2013)
31. Taupin P, "BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation", Brain Res Rev, 53, pp.198~214 (2007)
32. Ernst A, "Neurogenesis in the striatum of the adult human brain", Cell, 156, pp.1072~1083 (2014)
33. Ernst A, "Adult neurogenesis in humans-common and unique traits in mammals", PLoS Biol, 13, pp.e1002045~ (2015)
34. Penney J, "Modeling Alzheimer’s disease with iPSC-derived brain cells", Mol Psychiatry, 25, pp.148~167 (2020)
35. Ross CA, "Huntington disease: natural history, biomarkers and prospects for therapeutics", Nat Rev Neurol, 10, pp.204~216 (2014)
36. Volkow ND, "Neurobiologic advances from the brain disease model of addiction", N Engl J Med, 374, pp.363~371 (2016)
37. Martynoga B, "Molecular control of neurogenesis : a view from the mammalian cerebral cortex", Cold Spring Harb Perspect Biol, 4, pp.a008359~ (2012)
38. Lindvall O, "Neurogenesis following stroke affecting the adult brain", Cold Spring Harb Perspect Biol, 7, pp.a019034~ (2015)
39. Spalding KL, "Dynamics of hippocampal neurogenesis in adult humans", Cell, 153, pp.1219~1227 (2013)
40. Moreno-Jiménez EP, "Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease", Nat Med, 25, pp.554~560 (2019)
41. Boldrini M, "Human hippocampal neurogenesis persists throughout aging", Cell Stem Cell, 22, pp.589~599 (2018)
42. Sorrells SF, "Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults", Nature, 555, pp.377~381 (2018)
43. Weissleder C, "Important unanswered questions about adult neurogenesis in schizophrenia", Curr Opin Psychiatry, 32, pp.170~178 (2019)
44. van Praag H, "Neural consequences of environmental enrichment", Nat Rev Neurosci, 1, pp.191~198 (2000)
45. Martinowich K, "Interaction between BDNF and serotonin : role in mood disorders", Neuropsychopharmacology, 33, pp.73~83 (2008)
46. Thompson Ray M, "Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders", J Psychiatry Neurosci, 36, pp.195~203 (2011)
47. Venkatasubramanian G, "Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia", Am J Psychiatry, 164, pp.1557~1560 (2007)
48. Weissleder C, "Reduction in IGF1 mRNA in the human subependymal zone during aging", Aging Dis, 10, pp.197~204 (2019)
49. Gitto E, "Oxidative stress of the newborn in the pre-and postnatal period and the clinical utility of melatonin", J Pineal Res, 46, pp.128~139 (2009)
50. Paulsen Bda S, "Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient", Cell Transplant, 21, pp.1547~1559 (2012)
51. Brennand K, "Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia", Mol Psychiatry, 20, pp.361~368 (2015)
52. Kim Y, "Rapamycin increases the incidence of neuropsychiatric illness in kidney transplant patients through the suppression of neural stem cells", Transl Psychiatry, 10, pp.156~ (2020)
53. Topol A, "Altered WNT signaling in human induced pluripotent stem cell neural progenitor cells derived from four schizophrenia patients", Biol Psychiatry, 78, pp.e29~e34 (2015)
54. Ribeiro Xavier AL, "A distinct population of microglia supports adult neurogenesis in the subventricular zone", J Neurosci, 35, pp.11848~11861 (2015)
55. Solano Fonseca R, "Neurogenic niche microglia undergo positional remodeling and progressive activation contributing to age-associated reductions in neurogenesis", Stem Cells Dev, 25, pp.542~555 (2016)
56. Borsini A, "The role of inflammatory cytokines as key modulators of neurogenesis", Trends Neurosci, 38, pp.145~157 (2015)
57. van Kesteren CF, "Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies", Transl Psychiatry, 7, pp.e1075~ (2017)
58. Goldsmith DR, "A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression", Mol Psychiatry, 21, pp.1696~1709 (2016)
59. Kang E, "Adult Neurogenesis and Psychiatric Disorders", Cold Spring Harb Perspect Biol, 8, pp.a019026~ (2016)
60. Wright IC, "Meta-analysis of regional brain volumes in schizophrenia", Am J Psychiatry, 157, pp.16~25 (2000)
61. Keilp JG, "Cognitive impairment in schizophrenia : specific relations to ventricular size and negative symptomatology", Biol Psychiatry, 24, pp.47~55 (1988)
62. Andreasen NC, "Ventricular enlargement in schizophrenia : relationship to positive and negative symptoms", Am J Psychiatry, 139, pp.297~302 (1982)
63. Pearlson GD, "Ventricle-brain ratio, computed tomographic density, and brain area in 50 schizophrenics", Arch Gen Psychiatry, 46, pp.690~697 (1989)
64. Losonczy MF, "Correlates of lateral ventricular size in chronic schizophrenia, I: behavioral and treatment response measures", Am J Psychiatry, 143, pp.976~981 (1986)
65. Bernstein HG, "Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia", Schizophr Res, 33, pp.125~132 (1998)
66. Roussos P, "Activity-dependent changes in gene expression in schizophrenia human-induced pluripotent stem cell neurons", JAMA Psychiatry, 73, pp.1180~1188 (2016)
67. Robicsek O, "Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients", Mol Psychiatry, 18, pp.1067~1076 (2013)
68. Hartley BJ, "Dopaminergic differentiation of schizophrenia hiPSCs", Mol Psychiatry, 20, pp.549~550 (2015)
69. Howes OD, "The dopamine hypothesis of schizophrenia : version III--the final common pathway", Schizophr Bull, 35, pp.549~562 (2009)
70. Sorg C, "Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia", Schizophr Bull, 39, pp.387~395 (2013)
71. McCutcheon RA, "Schizophrenia, dopamine and the striatum: from biology to symptoms", Trends Neurosci, 42, pp.205~220 (2019)
72. Kippin TE, "Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs", J Neurosci, 25, pp.5815~5823 (2005)
73. Hook V, "Human iPSC neurons display activity-dependent neurotransmitter secretion : aberrant catecholamine levels in schizophrenia neurons", Stem Cell Reports, 3, pp.531~538 (2014)
74. Howes OD, "and dopamine in the development of schizophrenia", Biol Psychiatry, 81, pp.9~20 (2017)
75. Schizophrenia Working Group of the Psychiatric Genomics Consortium, "Biological insights from 108 schizophrenia-associated genetic loci", Nature, 511, pp.421~427 (2014)
76. Peciña M, "DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience", Cortex, 49, pp.877~890 (2013)
77. Hranilovic D, "Emotional response in dopamine D2L receptor-deficient mice", Behav Brain Res, 195, pp.246~250 (2008)
78. Emamian ES, "Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia", Nat Genet, 36, pp.131~137 (2004)
79. Ishizuka K, "Evidence that many of the DISC1 isoforms in C57BL", 6J mice are also expressed in 129S6, Mol Psychiatry, pp.2007, 12[DOI]
80. Brandon NJ, "Linking neurodevelopmental and synaptic theories of mental illness through DISC1", Nat Rev Neurosci, 12, pp.707~722 (2011)
81. Millar JK, "DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling", Science, 310, pp.1187~1191 (2005)
82. Deng X, "Positive association of phencyclidine-responsive genes, PDE4A and PLAT, with schizophrenia", Am J Med Genet B Neuropsychiatr Genet, 156, pp.850~858 (2011)
83. Ikemoto K, "D-neuron in schizophrenia research", Advances in Biosensors and Bioelectronics, 2, pp.35~38 (2013)
84. Koblan KS, "A non-D2-receptor-binding drug for the treatment of schizophrenia", N Engl J Med, 382, pp.1497~1506 (2020)
85. Gainetdinov RR, "Trace amines and their receptors", Pharmacol Rev, 70, pp.549~620 (2018)
86. Lindemann L, "Trace amine-associated receptor 1 modulates dopaminergic activity", J Pharmacol Exp Ther, 324, pp.948~956 (2008)
87. Panas HN, "Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice", J Neurosci Res, 88, pp.1962~1969 (2010)
88. Revel FG, "A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight", Mol Psychiatry, 18, pp.543~556 (2013)
89. Carlsson A, "Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain", Acta pharmacologica et toxicologica, 20, pp.140~144 (1963)
90. Davis KL, "Dopamine in schizophrenia : a review and reconceptualization", Am J Psychiatry, 148, pp.1474~1486 (1991)

관련 논문AI추천